$0.840
-0.029 (-3.46%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Organogenesis Holdings Inc (ORGO) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting ORGO is Strong sell.
Organogenesis Holdings Inc (ORGO) 20-Day simple moving average is 0.98, while Organogenesis Holdings Inc (ORGO) share price is $—, making it Sell.
Organogenesis Holdings Inc (ORGO) 60-Day simple moving average is 1.36, while Organogenesis Holdings Inc (ORGO) share price is $—, making it Sell.
Technical Analysis for ORGO
AI Technical ORGOAs of 2026-11-03, the technical board for Organogenesis Holdings Inc (ORGO) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $0.84 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 30.178, MACD stands at -0.146 (Sell), Stochastic %K stands at 29.869, Stochastic %D stands at 20.811 and CCI stands at -74.918.
ORGO trades below the 60-day SMA (1.36) and below the 200-day SMA (2.31). Immediate resistance sits at Classic R1 1.01, then R2 1.17. Support sits at Classic S1 0.71, then S2 0.57.
Organogenesis Holdings Inc (ORGO) Support & Resistance Level
Organogenesis Holdings Inc (ORGO) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 30.178 |
| STOCHk_14_3_3 | 29.869 |
| STOCHd_14_3_3 | 20.811 |
| CCI_20 | -74.918 |
| AO_5_34 | -0.332 |
| MOM_10 | -0.190 |
| MACD_12_26_9 | -0.146 |
Organogenesis Holdings Inc (ORGO) Relative Strength Index (RSI_14) is 30.178, creating a Neutral signal.
Organogenesis Holdings Inc (ORGO) Stochastic %K is 29.869, creating a Neutral signal.
Organogenesis Holdings Inc (ORGO) Stochastic %D is 20.811, creating a Neutral signal.
Organogenesis Holdings Inc (ORGO) CCI_20 is -74.918, creating a Neutral signal.
Organogenesis Holdings Inc (ORGO) Awesome Oscillator (AO) is -0.332, creating a Sell signal.
Organogenesis Holdings Inc (ORGO) Momentum (MOM) is -0.190, creating a Sell signal.
Organogenesis Holdings Inc (ORGO) Moving Average Convergence Divergence (MACD) is -0.146, creating a Sell signal.
Organogenesis Holdings Inc (ORGO) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.814 | Buy |
| MA_10 | 0.854 | Sell |
| MA_20 | 0.979 | Sell |
| MA_60 | 1.363 | Sell |
| MA_200 | 2.312 | Sell |
| MA_250 | 2.861 | Sell |
Organogenesis Holdings Inc (ORGO) 5-Day simple moving average is 0.814, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Buy.
Organogenesis Holdings Inc (ORGO) 10-Day simple moving average is 0.854, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Sell.
Organogenesis Holdings Inc (ORGO) 20-Day simple moving average is 0.979, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Sell.
Organogenesis Holdings Inc (ORGO) 60-Day simple moving average is 1.363, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Sell.
Organogenesis Holdings Inc (ORGO) 200-Day simple moving average is 2.312, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Sell.
Organogenesis Holdings Inc (ORGO) 250-Day simple moving average is 2.861, while Organogenesis Holdings Inc (ORGO) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.